Fatty acids, lipid mediators, and T-cell function

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  de Jong, Anja J ^a   Kloppenburg, Margreet ^a   Toes, René E M ^a   Ioan Facsinay, Andreea ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fatty acids; Inflammation; Lipid mediators; Obesity; T cells

Indexed keywords

BUTYRIC ACID; CD4 ANTIGEN; CD59 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; FATTY ACID; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; FATTY ACID TRANSPORTER; G PROTEIN COUPLED RECEPTOR 40; GAMMA INTERFERON; GAMMA LINOLENIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; LAURIC ACID; LIPID; LIPOXIN A; MONOUNSATURATED FATTY ACID; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E2; SATURATED FATTY ACID; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

BINDING AFFINITY; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MIGRATION; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIETARY INTAKE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LIPID STORAGE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 84918769152     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00483     Document Type: Review

References (87)

1. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 11:85-97. doi:10.1038/nri2921
2. Hotamisligil GS. Inflammation and metabolic disorders. Nature (2006) 444:860-7. doi:10.1038/nature05485
3. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol (2007) 3:716-24. doi:10.1038/ncprheum0674
4. Yusuf E, Nelissen RG, Ioan-Facsinay A, Stojanovic-Susulic V, DeGroot J, van OG, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis (2010) 69:761-5. doi:10.1136/ard.2008.106930
5. van der Helm-van Mil AH, van der Kooij SM, Allaart CF, Toes RE, Huizinga TW. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis (2008) 67:769-74. doi:10.1136/ard.2007.078832
6. Paik J, Fierce Y, Treuting PM, Brabb T, Maggio-Price L. High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-/- male mice. J Nutr (2013) 143:1240-7. doi:10.3945/jn.113.174615
7. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis (2006) 6:438-46. doi:10.1016/S1473-3099(06)70523-0
8. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) (2012) 36:1072-7. doi:10.1038/ijo.2011.208
9. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab (2004) 89:2548-56. doi:10.1210/jc.2004-0395
10. Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm (2010) 2010:513948. doi:10.1155/2010/513948
11. Anderson EK, Gutierrez DA, Hasty AH. Adipose tissue recruitment of leukocytes. Curr Opin Lipidol (2010) 21:172-7. doi:10.1097/MOL.0b013e3283393867
12. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol (2005) 115:911-9. doi:10.1016/j.jaci.2005.02.023
13. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am (2008) 37:635-6. doi:10.1016/j.ecl.2008.06.007
14. Bjorntorp P, Bergman H, Varnauskas E. Plasma free fatty acid turnover rate in obesity. Acta Med Scand (1969) 185:351-6. doi:10.1111/j.0954-6820.1969.tb07347.x
15. OPIE LH, WALFISH PG. Plasma free fatty acid concentrations in obesity. N Engl J Med (1963) 268:757-60. doi:10.1056/NEJM196304042681404
16. Perreault M, Roke K, Badawi A, Nielsen DE, Abdelmagid SA, El-Sohemy A, et al. Plasma levels of 14:0, 16:0, 16:1n-7, and 20:3n-6 are positively associated, but 18:0 and 18:2n-6 are inversely associated with markers of inflammation in young healthy adults. Lipids (2014) 49:255-63. doi:10.1007/s11745-013-3874-3
17. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev (2010) 68:280-9. doi:10.1111/j.1753-4887.2010.00287.x
18. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 23:e20-30. doi:10.1161/01.ATV.0000038493.65177.94
19. Vessby B. Dietary fat and insulin action in humans. Br J Nutr (2000) 83(Suppl 1):S91-6. doi:10.1017/S000711450000101X
20. Marshall JA, Bessesen DH. Dietary fat and the development of type 2 diabetes. Diabetes Care (2002) 25:620-2. doi:10.2337/diacare.25.3.620
21. Harrison LM, Balan KV, Babu US. Dietary fatty acids and immune response to food-borne bacterial infections. Nutrients (2013) 5:1801-22. doi:10.3390/nu5051801
22. Anderson M, Fritsche KL. (n-3) Fatty acids and infectious disease resistance. J Nutr (2002) 132:3566-76.
23. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol (2007) 25:101-37. doi:10.1146/annurev.immunol.25.022106.141647
24. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol (2008) 8:349-61. doi:10.1038/nri2294
25. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients (2011) 3:858-76. doi:10.3390/nu3100858
26. Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients (2010) 2:355-74. doi:10.3390/nu2030355
27. Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids (2008) 79:101-8. doi:10.1016/j.plefa.2008.09.016
28. Akhtar KN. Polyunsaturated fatty acids in the modulation of T-cell signalling. Prostaglandins Leukot Essent Fatty Acids (2010) 82:179-87. doi:10.1016/j.plefa.2010.02.023
29. Zurier RB, Rossetti RG, Seiler CM, Laposata M. Human peripheral blood T lymphocyte proliferation after activation of the T cell receptor: effects of unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids (1999) 60:371-5. doi:10.1016/S0952-3278(99)80015-5
30. Lima TM, Kanunfre CC, Pompeia C, Verlengia R, Curi R. Ranking the toxicity of fatty acids on Jurkat and Raji cells by flow cytometric analysis. Toxicol In vitro (2002) 16:741-7. doi:10.1016/S0887-2333(02)00095-4
31. Cury-Boaventura MF, Pompeia C, Curi R. Comparative toxicity of oleic acid and linoleic acid on Jurkat cells. Clin Nutr (2004) 23:721-32. doi:10.1016/j.clnu.2003.12.004
32. Cury-Boaventura MF, Gorjao R, de Lima TM, Newsholme P, Curi R. Comparative toxicity of oleic and linoleic acid on human lymphocytes. Life Sci (2006) 78:1448-56. doi:10.1016/j.lfs.2005.07.038
33. Gorjao R, Cury-Boaventura MF, de Lima TM, Curi R. Regulation of human lymphocyte proliferation by fatty acids. Cell Biochem Funct (2007) 25:305-15. doi:10.1002/cbf.1388
34. Takahashi HK, Cambiaghi TD, Luchessi AD, Hirabara SM, Vinolo MA, Newsholme P, et al. Activation of survival and apoptotic signaling pathways in lymphocytes exposed to palmitic acid. J Cell Physiol (2012) 227:339-50. doi:10.1002/jcp.22740
35. Ioan-Facsinay A, Kwekkeboom JC, Westhoff S, Giera M, Rombouts Y, van HV, et al. Adipocyte-derived lipids modulate CD4(+) T-cell function. Eur J Immunol (2013) 43:1578-87. doi:10.1002/eji.201243096
36. Stentz FB, Kitabchi AE. Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation. Biochem Biophys Res Commun (2006) 346:721-6. doi:10.1016/j.bbrc.2006.05.159
37. Fernanda Cury-Boaventura M, Cristine KC, Gorjao R, Martins de LT, Curi R. Mechanisms involved in Jurkat cell death induced by oleic and linoleic acids. Clin Nutr (2006) 25:1004-14. doi:10.1016/j.clnu.2006.05.008
38. Szamel M, Rehermann B, Krebs B, Kurrle R, Resch K. Activation signals in human lymphocytes. Incorporation of polyunsaturated fatty acids into plasma membrane phospholipids regulates IL-2 synthesis via sustained activation of protein kinase C. J Immunol (1989) 143:2806-13.
39. Rossetti RG, Seiler CM, DeLuca P, Laposata M, Zurier RB. Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation. J Leukoc Biol (1997) 62:438-43.
40. Stahl A, Gimeno RE, Tartaglia LA, Lodish HF. Fatty acid transport proteins: a current view of a growing family. Trends Endocrinol Metab (2001) 12:266-73. doi:10.1016/S1043-2760(01)00427-1
41. Storch J, Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta (2000) 1486:28-44. doi:10.1016/S1388-1981(00)00046-9
42. Haunerland NH, Spener F. Fatty acid-binding proteins - insights from genetic manipulations. Prog Lipid Res (2004) 43:328-49. doi:10.1016/j.plipres.2004.05.001
43. Rolph MS, Young TR, Shum BO, Gorgun CZ, Schmitz-Peiffer C, Ramshaw IA, et al. Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2. J Immunol (2006) 177:7794-801. doi:10.4049/jimmunol.177.11.7794
44. Vinolo MA, Hirabara SM, Curi R. G-protein-coupled receptors as fat sensors. Curr Opin Clin Nutr Metab Care (2012) 15:112-6. doi:10.1097/MCO.0b013e32834f4598
45. Blad CC, Tang C, Offermanns S. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat Rev Drug Discov (2012) 11:603-19. doi:10.1038/nrd3777
46. Yonezawa T, Kurata R, Yoshida K, Murayama MA, Cui X, Hasegawa A. Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics. Curr Med Chem (2013) 20:3855-71. doi:10.2174/09298673113209990168
47. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem (2003) 278:11303-11. doi:10.1074/jbc.M211495200
48. Le PE, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem (2003) 278:25481-9. doi:10.1074/jbc.M301403200
49. Wang J, Wu X, Simonavicius N, Tian H, Ling L. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem (2006) 281:34457-64. doi:10.1074/jbc.M608019200
50. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly Y, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (2013) 341:569-73. doi:10.1126/science.1241165
51. Cury-Boaventura MF, Curi R. Regulation of reactive oxygen species (ROS) production by C18 fatty acids in Jurkat and Raji cells. Clin Sci (Lond) (2005) 108:245-53. doi:10.1042/CS20040281
52. Azevedo-Martins AK, Curi R. Fatty acids decrease catalase activity in human leukaemia cell lines. Cell Biochem Funct (2008) 26:87-94. doi:10.1002/cbf.1404
53. Tanaka S, Isoda F, Ishihara Y, Kimura M, Yamakawa T. T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin Endocrinol (Oxf) (2001) 54:347-54. doi:10.1046/j.1365-2265.2001.1139cn2155.x
54. Tanaka S, Isoda F, Yamakawa T, Ishihara M, Sekihara H. T lymphopenia in genetically obese rats. Clin Immunol Immunopathol (1998) 86:219-25. doi:10.1006/clin.1997.4467
55. Boynton A, Neuhouser ML, Wener MH, Wood B, Sorensen B, Chen-Levy Z, et al. Associations between healthy eating patterns and immune function or inflammation in overweight or obese postmenopausal women. Am J Clin Nutr (2007) 86:1445-55.
56. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord (1993) 17:631-6.
57. Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE, et al. Influence of obesity on immune function. J Am Diet Assoc (1999) 99:294-9. doi:10.1016/S0002-8223(99)00077-2
58. Mito N, Kitada C, Hosoda T, Sato K. Effect of diet-induced obesity on ovalbumin-specific immune response in a murine asthma model. Metabolism (2002) 51:1241-6. doi:10.1053/meta.2002.35196
59. Moussa M, Le BJ, Garcia J, Tkaczuk J, Ragab J, Dutot G, et al. In vivo effects of olive oil-based lipid emulsion on lymphocyte activation in rats. Clin Nutr (2000) 19:49-54. doi:10.1054/clnu.1999.0076
60. Yaqoob P, Newsholme EA, Calder PC. The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation. Immunology (1994) 82:603-10.
61. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature (2013) 504:446-50. doi:10.1038/nature12721
62. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 504:451-5. doi:10.1038/nature12726
63. Yaqoob P, Knapper JA, Webb DH, Williams CM, Newsholme EA, Calder PC. Effect of olive oil on immune function in middle-aged men. Am J Clin Nutr (1998) 67:129-35.
64. Han SN, Lichtenstein AH, Ausman LM, Meydani SN. Novel soybean oils differing in fatty acid composition alter immune functions of moderately hypercholesterolemic older adults. J Nutr (2012) 142:2182-7. doi:10.3945/jn.112.164335
65. Sreeramkumar V, Fresno M, Cuesta N. Prostaglandin E2 and T cells: friends or foes? Immunol Cell Biol (2012) 90:579-86. doi:10.1038/icb.2011.75
66. Lone AM, Tasken K. Proinflammatory and immunoregulatory roles of eicosanoids in T cells. Front Immunol (2013) 4:130. doi:10.3389/fimmu.2013.00130
67. Lee BP, Juvet SC, Zhang L. Prostaglandin E2 signaling through E prostanoid receptor 2 impairs proliferative response of double negative regulatory T cells. Int Immunopharmacol (2009) 9:534-9. doi:10.1016/j.intimp.2009.01.023
68. English K, Tonlorenzi R, Cossu G, Wood KJ. Mesoangioblasts suppress T cell proliferation through IDO and PGE-2-dependent pathways. Stem Cells Dev (2013) 22:512-23. doi:10.1089/scd.2012.0386
69. Bao YS, Zhang P, Xie RJ, Wang M, Wang ZY, Zhou Z, et al. The regulation of CD4+ T cell immune responses toward Th2 cell development by prostaglandin E2. Int Immunopharmacol (2011) 11:1599-605. doi:10.1016/j.intimp.2011.05.021
70. Adamik J, Henkel M, Ray A, Auron PE, Duerr R, Barrie A. The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells. Cytokine (2013) 64:404-12. doi:10.1016/j.cyto.2013.05.010
71. Barrie A, Khare A, Henkel M, Zhang Y, Barmada MM, Duerr R, et al. Prostaglandin E2 and IL-23 plus IL-1beta differentially regulate the Th1/Th17 immune response of human CD161(+) CD4(+) memory T cells. Clin Transl Sci (2011) 4:268-73. doi:10.1111/j.1752-8062.2011.00300.x
72. Napolitani G, Acosta-Rodriguez EV, Lanzavecchia A, Sallusto F. Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells. Eur J Immunol (2009) 39:1301-12. doi:10.1002/eji.200838969
73. Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med (2009) 15:633-40. doi:10.1038/nm.1968
74. Machado ER, Carlos D, Lourenco EV, Souza GE, Sorgi CA, Silva EV, et al. Cyclooxygenase-derived mediators regulate the immunological control of Strongyloides venezuelensis infection. FEMS Immunol Med Microbiol (2010) 59:18-32. doi:10.1111/j.1574-695X.2010.00656.x
75. Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK, et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med (2009) 206:535-48. doi:10.1084/jem.20082293
76. Valdez PA, Vithayathil PJ, Janelsins BM, Shaffer AL, Williamson PR, Datta SK. Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity (2012) 36:668-79. doi:10.1016/j.immuni.2012.02.013
77. Parmentier CN, Fuerst E, McDonald J, Bowen H, Lee TH, Pease JE, et al. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1. J Allergy Clin Immunol (2012) 129:1136-42. doi:10.1016/j.jaci.2012.01.057
78. Secatto A, Rodrigues LC, Serezani CH, Ramos SG, Dias-Baruffi M, Faccioli LH, et al. 5-Lipoxygenase deficiency impairs innate and adaptive immune responses during fungal infection. PLoS One (2012) 7:e31701. doi:10.1371/journal.pone.0031701
79. Mothe-Satney I, Filloux C, Amghar H, Pons C, Bourlier V, Galitzky J, et al. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes (2012) 61:2311-9. doi:10.2337/db11-1455
80. Tristao FS, Rocha FA, Moreira AP, Cunha FQ, Rossi MA, Silva JS. 5-Lipoxygenase activity increases susceptibility to experimental Paracoccidioides brasiliensis infection. Infect Immun (2013) 81:1256-66. doi:10.1128/IAI.01209-12
81. Narushima S, DiMeo D, Tian J, Zhang J, Liu D, Berg DJ. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice. Am J Physiol Gastrointest Liver Physiol (2008) 294:G477-88. doi:10.1152/ajpgi.00229.2007
82. Chen H, Qin J, Wei P, Zhang J, Li Q, Fu L, et al. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells. Prostaglandins Leukot Essent Fatty Acids (2009) 80:195-200. doi:10.1016/j.plefa.2009.01.006
83. Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol (2003) 170:6266-72. doi:10.4049/jimmunol.170.12.6266
84. Spurr L, Nadkarni S, Pederzoli-Ribeil M, Goulding NJ, Perretti M, D'Acquisto F. Comparative analysis of Annexin A1-formyl peptide receptor 2/ALX expression in human leukocyte subsets. Int Immunopharmacol (2011) 11:55-66. doi:10.1016/j.intimp.2010.10.006
85. Settimio R, Clara DF, Franca F, Francesca S, Michele D. Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. Mediators Inflamm (2012) 2012:318621. doi:10.1155/2012/318621
86. Ariel A, Li PL, Wang W, Tang WX, Fredman G, Hong S, et al. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem (2005) 280:43079-86. doi:10.1074/jbc.M509796200
87. Levy BD, Kohli P, Gotlinger K, Haworth O, Hong S, Kazani S, et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol (2007) 178:496-502. doi:10.4049/jimmunol.178.1.496